Therapeutic potential of resveratrol in Alzheimer's disease
about
Dietary interventions to extend life span and health span based on calorie restrictionHerbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain functionAntioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal ResultsResveratrol: A Focus on Several Neurodegenerative DiseasesShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseResveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged MicePretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in RatsBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseResveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicityResveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generationNovel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis.Polyphenols and aging.Neuronutrition and Alzheimer's diseaseNeuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications.Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseasesResveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascadeResveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation.Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Nutrition in severe dementiaHepatoprotective and Antioxidant Potential of Organic and Conventional Grape Juices in Rats Fed a High-Fat Diet.A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and DepressionIdentification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages.Chronic depression as a model disease for cerebral agingAlzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy OutcomeDuality of Antidepressants and Neuroprotectants.Protein folding and aggregation into amyloid: the interference by natural phenolic compoundsNatural products as a source of Alzheimer's drug leads.Neuroinflammation, neurodegeneration, and depression.Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases.
P2860
Q24595003-99767372-F3E4-4CA8-B2DC-051BC97ABEF1Q24617577-4E610BE4-F3E3-425F-B851-FE22A69FBAD2Q26774897-74BDB1AB-48CA-4601-860B-19961B0044D1Q26800952-93332E85-7215-45D7-92C7-19EB7047C00AQ26830740-16EFABAB-CAC3-44AD-9A0F-3EB6811FA296Q27021700-6ACCC00B-95AC-4E7B-B3D7-2E4605D65C3EQ27335789-2AEC75A9-9504-4A63-A8AE-9783D0F30394Q27346253-FA09028D-40B5-4A19-B4F6-E27B4368EF6DQ28259585-EA001EBF-D99F-4870-8EEB-551B9D7D5D62Q28478772-CBED43F4-9EFF-4EC4-BADF-41F5CB01F925Q28488046-D2D56E4B-E803-407F-BF2A-65E35CBEDFB5Q28543122-02FE5AC4-66E5-4A13-81D1-2B2C4694845EQ33695751-269EF53E-41EE-44D3-913B-E832059359FEQ33726605-0B0A6025-FB89-4142-A1E8-DC7E7FFE5A2EQ33859252-F284F1DE-B07F-46DE-B8D3-0FAAFA9D42D5Q33925399-4682E7EC-CE05-499C-8CBA-72FCE4F2AA77Q33957220-0FB9C184-788F-42DF-A0A9-3DA909806BBCQ34099466-0CF630D7-62CD-40CC-9A66-BF2952D01BF3Q34215149-9FAA3E67-DE9F-40D6-9B45-F8A0B911DC0BQ34407220-A9CBADA2-87AE-4DF0-8DFF-35813B3D2CDFQ34412322-9030B2C7-B3A1-4A92-B4AE-B321A2DEE10EQ34443537-6BB9458A-4FD3-4DF0-A90A-0E770815AB8FQ35224775-6870A82D-4208-4E32-8CA8-3D8B2BF41598Q35658827-2E19B4C5-DABC-4A76-A616-D054D09E5D60Q35738555-EA91807B-FD55-4DA2-9D1C-4836A1900B80Q35765716-75C46B60-C4C9-47A2-B2FC-7BAB225AF65FQ35974826-1232CC17-1BF8-4D2E-B809-93D09AF3322BQ36335037-F1A97281-D7DF-455E-8964-D9B15120F943Q36378454-E4E5A218-02A2-4248-8D9D-CBE63DF39192Q36575930-3010DAFA-1EDC-4393-9F9E-7D22B812397AQ36755176-80D46970-F54D-4FA9-BCD7-F318A78DBEFCQ36781717-8C58A758-8760-4D4D-9FC9-D4B5B30425F6Q36944840-D0126FCE-E5EF-4E2B-A292-4C4FE59F89E2Q37007345-839A4D37-C4C4-4C44-9B09-BFF733DB1F15Q37029561-E9C82E6A-644C-4F86-AA0C-0EE20D4CB58EQ37116106-AF078EE7-A19B-442F-B0AD-9CA575BFD943Q37209501-D077DCD0-7C16-4CC1-AAA2-F1FB02837C7FQ37559812-7CDB72B3-05AA-4997-A9BE-606F32D9B654Q37675866-233841BA-3E43-4045-A902-DBB669899568Q37689874-71F91FB3-24F9-4EED-B56A-BD2FD02F7BA6
P2860
Therapeutic potential of resveratrol in Alzheimer's disease
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic potential of resveratrol in Alzheimer's disease
@ast
Therapeutic potential of resveratrol in Alzheimer's disease
@en
type
label
Therapeutic potential of resveratrol in Alzheimer's disease
@ast
Therapeutic potential of resveratrol in Alzheimer's disease
@en
prefLabel
Therapeutic potential of resveratrol in Alzheimer's disease
@ast
Therapeutic potential of resveratrol in Alzheimer's disease
@en
P2093
P2860
P921
P1433
P1476
Therapeutic potential of resveratrol in Alzheimer's disease
@en
P2093
Haitian Zhao
Peter Davies
Ute Dreses-Werringloer
P2860
P2888
P356
10.1186/1471-2202-9-S2-S6
P478
P5008
P577
2008-12-03T00:00:00Z
P6179
1003354581